rs17732513
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_006329.4(FBLN5):c.379+16912G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.278 in 152,044 control chromosomes in the GnomAD database, including 6,594 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.28 ( 6594 hom., cov: 32)
Consequence
FBLN5
NM_006329.4 intron
NM_006329.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.64
Publications
6 publications found
Genes affected
FBLN5 (HGNC:3602): (fibulin 5) The protein encoded by this gene is a secreted, extracellular matrix protein containing an Arg-Gly-Asp (RGD) motif and calcium-binding EGF-like domains. It promotes adhesion of endothelial cells through interaction of integrins and the RGD motif. It is prominently expressed in developing arteries but less so in adult vessels. However, its expression is reinduced in balloon-injured vessels and atherosclerotic lesions, notably in intimal vascular smooth muscle cells and endothelial cells. Therefore, the protein encoded by this gene may play a role in vascular development and remodeling. Defects in this gene are a cause of autosomal dominant cutis laxa, autosomal recessive cutis laxa type I (CL type I), and age-related macular degeneration type 3 (ARMD3). [provided by RefSeq, Jul 2008]
FBLN5 Gene-Disease associations (from GenCC):
- cutis laxa, autosomal dominant 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp
- cutis laxa, autosomal recessive, type 1AInheritance: SD, AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
- Charcot-Marie-Tooth disease, demyelinating, IIA 1HInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- demyelinating hereditary motor and sensory neuropathyInheritance: AD Classification: MODERATE Submitted by: ClinGen
- macular degeneration, age-related, 3Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- autosomal dominant cutis laxaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary sensorimotor neuropathy with hyperelastic skinInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- autosomal recessive cutis laxa type 1Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.348 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| FBLN5 | NM_006329.4 | c.379+16912G>A | intron_variant | Intron 4 of 10 | ENST00000342058.9 | NP_006320.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.278 AC: 42253AN: 151926Hom.: 6590 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
42253
AN:
151926
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.278 AC: 42258AN: 152044Hom.: 6594 Cov.: 32 AF XY: 0.278 AC XY: 20679AN XY: 74314 show subpopulations
GnomAD4 genome
AF:
AC:
42258
AN:
152044
Hom.:
Cov.:
32
AF XY:
AC XY:
20679
AN XY:
74314
show subpopulations
African (AFR)
AF:
AC:
5543
AN:
41476
American (AMR)
AF:
AC:
3917
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
940
AN:
3470
East Asian (EAS)
AF:
AC:
1858
AN:
5148
South Asian (SAS)
AF:
AC:
1199
AN:
4820
European-Finnish (FIN)
AF:
AC:
3945
AN:
10562
Middle Eastern (MID)
AF:
AC:
64
AN:
294
European-Non Finnish (NFE)
AF:
AC:
23909
AN:
67966
Other (OTH)
AF:
AC:
560
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1507
3015
4522
6030
7537
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
438
876
1314
1752
2190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
851
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.